Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03957915
Title Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia (INA03)
Acronym INA03
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institut Paoli-Calmettes
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Paoli-Calmettes Marseille Bouches-du Rhône 13009 France Details
Chu Bordeaux Hopital Haut Leveque Pessac 33604 France Details
IUCT Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field